March 14, 2025
Movilitas.Cloud Earns Gateway Certified™ Accreditation for VRS Solution
Movilitas.Cloud: VRS Verify™ Accreditation Lexington, MA, March 14, 2025 – Gateway Checker, the industry’s leading independent GS1 Conformance Testing Service, today announced Movilitas.Cloud, as part of Engineering Industries eXcellence, has become the first product verification solution provider to successfully attain both Level 1 and Level 2 Gateway Certified™ VRS Verify™ accreditation. The FDA Drug Supply […]
March 13, 2025
Why You Need VRS Validation
The Importance of Validating Product-Verification Systems As discussed recently, VRS Systems are the most effective way to verify product in accordance with DSCSA regulations. Additionally, the widespread use of VRS Systems provides invaluable information to trade partners, including product-specific information such as supply status by trade partner, volume of activity, and location. Furthermore, immediate product […]
March 12, 2025
Who Needs Product Verification, and Why It’s Important for the DSCSA and Beyond
How VRS Benefits the Entire Pharmaceutical Supply Chain Last Friday, I described the importance of Verification Router Service (VRS) systems, introducing the benefits they provide within the pharmaceutical supply chain. As emphasized previously, the value of VRS systems extends beyond saleable returns, helping streamline product verification for trading partners and ensure product legitimacy. In this […]
March 7, 2025
Beyond Saleable Returns: The Benefit of VRS Systems
What is a VRS System, and What Value Does it Provide? Under the Drug Supply Chain Security Act (DSCSA), US pharmaceutical trading partners are required to verify the Product Identifier (PID) of a pharmaceutical product when items are suspect or considered for saleable returns. To deploy a widely available (and highly responsive) product verification system […]
February 4, 2025
How to Best Prepare for Final DSCSA Deadlines
DSCSA Deadline: Coming Soon As highlighted numerous times since its announcement, the FDA has provided an exemption for certain eligible trading partners from Enhanced Drug Distribution Security (EDDS) Requirements of the Drug Supply Chain Security Act (DSCSA). These exemptions vary in length depending on the trade partner; for manufacturers and repackagers, the deadline for compliance […]
